Our Leadership Team
Tufail Syed - CEO
Tufail has over 17 years of exposure to clinical trials business through engagements such as at Eli Lilly and Company, Medpace and Covance where Tufail held key global senior management and executive roles. Tufail brings to Q-Pharm a proven track record of a strong business leader with deep expertise in leading business transformation and expansion.
Having diverse experience as a physician, basic researcher, medical affairs professional and a global business leader, Tufail combines unique skills to lead Q-Pharm to be the reliable partner of choice for our clients and research participants. Tufail trained as a physician in India and earned his MBA from Rutgers Business School, New Jersey. Tufail is passionate about bringing new medicines and therapies to patients and improving lives through clinical research. Tufail founded the world’s largest clinical research society in 2006. He is also a member of the Australian Institute of Company Directors.
In his leisure time, Tufail likes to spend time with his family. He is an avid photographer and mountaineer
Craig Hurren - Global Head of Business Development
Craig has deep and broad knowledge of sales & marketing in healthcare and allied services, having started his career as a two-time National Sales Champion medical representative for Astra Pharmaceuticals in Australia, and rising to State Sales Manager before moving onto Regional Sales Manager at Novartis Australia, then National Sales Manager, Primary Care Products at Novartis. He was then asked to head the Healthcare Sales and Marketing operation as Vice President, Healthcare Alliance at DKSH (DiethelmKellerSieberHegner) in the Philippines, after which he took the reigns as Regional Head of Field Force Effectiveness, DKSH Asia, then became General Manager Sales & Marketing for DKSH Healthcare Thailand, the largest of their global operations, with over 750 professional sales and marketing staff in his reporting lines. Craig then did freelance consulting and executive coaching, and published two thriller novels before joining Q-Pharm as Global Head of Business Development in October, 2016.
Brad Joblin - Chief Scientific Officer
Brad has a doctorate from the University of Zurich. Having held senior management and director positions in clinical research at the headquarters of global pharmaceutical companies and smaller biotech companies, Bradley’s experience is in clinical study implementation, early and late phase clinical study design and clinical development strategy. Bradley founded his own company providing clinical study and development advice to the clinical research community including biotech companies and medical research institutes. Brad joined QPharm at the start of in 2017 to provide scientific oversight and management within Qpharm, as well as study design and development strategies to clients.
Dr Paul Griffin – Medical Director
Dr Paul Griffin is a Senior Lecturer in Medicine and Director of Infectious Diseases at the University of Queensland and Mater Hospitals, South Brisbane, Australia. He has fellowships in Infectious Diseases from the Royal Australasian College of Physicians, in Clinical Microbiology from the Royal College of Pathologists of Australasia and from the Australasian College of Tropical Medicine as well as an Associate Fellowship from the Australasian College of Health Service Management. He is the Principal Investigator and Manager of Medical Services at Q-Pharm; a specialized contract research organisation within QIMR Berghofer specializing in early and late phase trials in infectious diseases where he has been the principal investigator on in excess of 42 clinical trials predominantly in Infectious Diseases. Concurrently he maintains a joint appointment as a scientist at QIMR Berghofer/Mater Medical Research Institute with a primary research interest in tropical medicine particularly malaria human challenge studies. Finally, as a practising Clinical Microbiologist, he maintains an active interest in diagnostic microbiology with a focus on the detection of antibiotic resistance particularly VRE with MALDI-TOF MS.
Mary-Anne Kedda, PhD - Head of Project Management
Mary-Anne joined Q-Pharm in late 2017, as the Head of Project Management, Data & Recruitment. Mary-Anne has a PhD in Human Genetics and a Master of Public Health, and a strong background in academia, science and clinical trials project management. Until recently, she was the Clinical Registry Manager at the Australian Prostate Cancer Research Centre in Queensland and, prior to that, she was the Clinical Trials Manager at the Department of Radiation Oncology at Sir Charles Gairdner Hospital in Perth, Western Australia (WA), which is the largest public provider of Radiation Oncology services in WA. Mary-Anne has also worked in Europe and she maintains her role of Adjunct Associate Professor at the School of Population Health at the University of Western Australia.
Rob Box - Head of Business Services
Rob has a Master of Commerce and is a member of the Institute of Chartered Accountants with over 30 years of experience in finance. He brings knowledge and experience from a variety of industries including Manufacturing, Retail, and the Motor Industry. His career also includes 14 years as Manager and Owner of a distribution company. Rob has been with Q-Pharm for over 10 years and brings a passion for Finance, Planning and Analysis to the Q-Pharm Management team.
Andrew King - Head of Quality Assurance
As Head– Quality Assurance, Andrew King is responsible for the quality management system used to conduct clinical trials according to Good Clinical (Research) Practice, GCP. He is the primary contact for external audits of Q-Pharm.
Andrew has designed and defended at audit and inspection quality management systems for GCP, GLP and Research and Development (for a world-first accreditation). A biochemist by training, he has more than 30 years’ experience in drug disposition medical research, bioanalysis and clinical trials. He is co-author of more than 20 refereed research articles and has presented papers and posters on scientific and quality assurance topics at numerous conferences and meetings. He has been a NATA Technical Assessor for 20 years, member of the NATA R&D Steering Group and is Australia’s representative on the OECD Discussion Group on GLP. Management experience includes military management to the operational level and directorship. Andrew is a Fellow of the Research Quality Association, inaugural Chairman of its Australasian Regional Forum, Publications Committee member and a regular contributor to the Association’s magazine, Quasar.
Sharon Rankine - Head of Clinical Operations
Sharon is a highly experienced coronary and critical care nurse with extensive experience in healthy volunteer and patient based clinical trials. She is responsible for management of Q-Pharm's clinical operations, and acts as project manager on studies requiring special clinical skills.
Ben Tan, MBBS MSc - Senior Medical Advisor
Lai Hock (Ben) recently joined Q-Pharm as Senior Medical Advisor. He is a trained medical doctor with special interests in pharmaceutical medicine and clinical pharmacology. He comes to Q-pharm with over 17 years of clinical research experience, in particular early phase trials. Prior to joining Q-pharm, he had worked in various global pharmaceutical companies including Pfizer, MSD and Lilly as a pharmaceutical physician and Principal Investigator.